Literature DB >> 11725927

Properties of multiple intersection-union tests for multiple endpoints in combination therapy trials.

P H Westfall1, S Y Ho, B A Prillaman.   

Abstract

We consider intersection-union tests involving multiple endpoints in a combination drug trial, for which we control the familywise error rate in the strong sense using closed testing methods. Bonferroni-Holm, Simes-Hommel, and Resampling-Based methods all are considered in this context. Familywise error rate control heuristics are developed and evaluated using a simulation study that is specifically tailored to the intersection-union setting. Both Resampling-Based and Simes-Hommel uniformly outperform the Bonferroni-Holm. Using simulations of power, the choice of Simes-Hommel versus Resampling-Based is seen to depend on the particular alternative of interest. Because it is simpler and has generally good power, we recommend the Simes-Hommel intersection-union tests. The techniques are illustrated using real data from a clinical trial to evaluate a combination asthma therapy.

Mesh:

Substances:

Year:  2001        PMID: 11725927     DOI: 10.1081/BIP-100107653

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  2 in total

1.  Generalized Confidence Intervals Compatible with the Min Test for Simultaneous Comparisons of One Subpopulation to Several Other Subpopulations.

Authors:  Julia N Soulakova
Journal:  Commun Stat Theory Methods       Date:  2017-06-07       Impact factor: 0.893

2.  Expected loss functions as additional measures to assess performance of multiple testing procedures for combination drug dose finding.

Authors:  Julia N Soulakova; Allan R Sampson
Journal:  Pharm Stat       Date:  2012-03-06       Impact factor: 1.894

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.